Systemic bevacizumab (Avastin) therapy for exudative neovascular age-related macular degeneration. The BEAT-AMD-Study
Schmid-Kubista, K E, Krebs, I, Gruenberger, B, Zeiler, F, Schueller, J, Binder, SVolume:
93
Language:
english
Journal:
British Journal of Ophthalmology
DOI:
10.1136/bjo.2008.144410
Date:
July, 2009
File:
PDF, 665 KB
english, 2009